GERN – Geron Corporation

Float Short %

12.74

Margin Of Safety %

Put/Call OI Ratio

0.21

EPS Next Q Diff

EPS Last/This Y

0.15

EPS This/Next Y

0.04

Price

1.36

Target Price

3.6

Analyst Recom

Performance Q

7.09

Relative Volume

1.06

Beta

0.6

Ticker: GERN

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-13	GERN	1.15	0.06	0.47	94309
2025-11-14	GERN	1.12	0.06	16.95	95867
2025-11-17	GERN	1.135	0.11	7.81	100004
2025-11-18	GERN	1.1	0.15	1.71	103901
2025-11-19	GERN	1.085	0.16	0.08	105567
2025-11-20	GERN	1.105	0.16	0.83	105643
2025-11-21	GERN	1.12	0.16	0.00	106171
2025-11-24	GERN	1.155	0.17	0.36	100870
2025-11-25	GERN	1.155	0.16	0.01	100844
2025-11-26	GERN	1.19	0.16	0.43	100757
2025-12-01	GERN	1.195	0.16	0.01	103540
2025-12-02	GERN	1.24	0.16	0.02	103566
2025-12-03	GERN	1.275	0.16	0.00	103863
2025-12-04	GERN	1.265	0.16	0.00	103731
2025-12-05	GERN	1.315	0.16	0.01	104213
2025-12-08	GERN	1.265	0.16	0.77	104709
2025-12-09	GERN	1.23	0.21	0.01	114469
2025-12-10	GERN	1.295	0.21	0.00	114576
2025-12-11	GERN	1.38	0.21	0.01	114526
2025-12-12	GERN	1.36	0.21	0.21	114603
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-13	GERN	1.15	0.8	-8.8	-0.14
2025-11-14	GERN	1.12	-12.4	-12.9	-0.14
2025-11-17	GERN	1.13	15.7	-17.5	-0.12
2025-11-18	GERN	1.10	15.7	-12.8	-0.12
2025-11-19	GERN	1.08	15.7	-13.2	-0.12
2025-11-20	GERN	1.11	15.7	-17.6	-0.12
2025-11-21	GERN	1.12	1.7	-17.6	-0.12
2025-11-24	GERN	1.15	1.7	-18.4	-0.12
2025-11-25	GERN	1.16	1.7	-15.0	-0.12
2025-11-26	GERN	1.20	1.7	-19.1	-0.12
2025-12-01	GERN	1.20	1.7	-17.4	-0.12
2025-12-02	GERN	1.23	1.7	-18.2	-0.12
2025-12-03	GERN	1.27	1.7	-18.9	-0.12
2025-12-04	GERN	1.26	1.7	-15.4	-0.12
2025-12-05	GERN	1.31	1.7	-18.6	-0.12
2025-12-08	GERN	1.27	1.7	-	-0.12
2025-12-09	GERN	1.23	1.7	-13.6	-0.12
2025-12-10	GERN	1.23	1.7	-20.7	-0.12
2025-12-11	GERN	1.39	1.7	-22.0	-0.12
2025-12-12	GERN	1.36	1.7	-13.9	-0.12
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-13	GERN	0.04	-0.25	14.10
2025-11-14	GERN	0.00	-0.25	14.06
2025-11-17	GERN	0.00	0.58	14.12
2025-11-18	GERN	0.00	0.58	14.12
2025-11-19	GERN	0.00	0.58	14.12
2025-11-20	GERN	0.00	0.58	14.12
2025-11-21	GERN	0.00	0.58	14.12
2025-11-24	GERN	0.00	-1.00	14.04
2025-11-25	GERN	0.00	-1.00	14.04
2025-11-26	GERN	0.00	-1.00	12.78
2025-12-01	GERN	0.00	-1.04	12.78
2025-12-02	GERN	0.00	-1.04	12.78
2025-12-03	GERN	0.00	-1.04	12.78
2025-12-04	GERN	0.00	-1.04	12.78
2025-12-05	GERN	0.00	-1.04	12.78
2025-12-08	GERN	0.00	-1.06	12.78
2025-12-09	GERN	0.00	-1.06	12.78
2025-12-10	GERN	0.00	-1.06	12.74
2025-12-11	GERN	0.00	-1.06	12.74
2025-12-12	GERN	0.00	-1.06	12.74
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[stock_market_widget type="chart" template="candlestick" assets="GERN" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

-0.03

Avg. EPS Est. Current Quarter

-0.04

Avg. EPS Est. Next Quarter

-0.03

Insider Transactions

Institutional Transactions

-1.06

Beta

0.6

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

74.5

Max Drawdown 5-Year %

-79

Target Price

3.6

P/E

Forward P/E

PEG

P/S

4.73

P/B

3.49

P/Free Cash Flow

EPS

-0.12

Average EPS Est. Cur. Y

-0.12

EPS Next Y. (Est.)

-0.08

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-43.61

Relative Volume

1.06

Return on Equity vs Sector %

-59.1

Return on Equity vs Industry %

-44.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-13.9

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”GERN” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”GERN” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”GERN” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”GERN” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”GERN” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”GERN” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”GERN” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]

Geron Corporation

Sector: Healthcare

Industry: Biotechnology

Employees: 229

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

stock quote shares GERN – Geron Corporation Stock Price stock today

news today GERN – Geron Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch GERN – Geron Corporation yahoo finance google finance

stock history GERN – Geron Corporation invest stock market

stock prices GERN premarket after hours

ticker GERN fair value insiders trading

GERN – Geron Corporation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: GERN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y